Back to Search
JENNIFER O'DONOGHUE, PHD, LAT, ATC, CSCS
PHD, LAT, ATC, CSCS
Athletic Trainer
NPI: 1801161351Individual
Specialties, Licenses & Credentials
Athletic TrainerPrimary
Specialist/Technologist — Athletic Trainer
Code: 2255A2300X
0641(NC)
Research & Publications (20)
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
PMID 15817355·Int J Radiat Oncol Biol Phys·2005
4-observational
Relevance of external beam dose-response relationships to kidney toxicity associated with radionuclide therapy.
PMID 15285886·Cancer Biother Radiopharm·2004
6-review
Hematologic toxicity in radioimmunotherapy: dose-response relationships for I-131 labeled antibody therapy.
PMID 12396707·Cancer Biother Radiopharm·2002
8-other
Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.
PMID 10716330·J Nucl Med·2000
4-observational
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.
PMID 19420418·Phys Med Biol·2009
8-other
Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.
PMID 19242606·Neoplasia·2009
7-preclinical
Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?
PMID 19520288·Nucl Med Biol·2009
7-preclinical
Anterior rectus sheath repair with porcine collagen (Permacol) in patients undergoing breast reconstruction with free abdominal flaps.
PMID 19010755·J Plast Reconstr Aesthet Surg·2009
4-observational
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
PMID 19364960·J Clin Oncol·2009
3-trial
Image deconvolution in digital autoradiography: a preliminary study.
PMID 18383673·Med Phys·2008
7-preclinical
Intrapleural bupivicaine in latissimus dorsi breast reconstruction.
PMID 18724122·Ann Plast Surg·2008
8-other
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy.
PMID 18552139·J Nucl Med·2008
3-trial
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
PMID 18355690·Nucl Med Biol·2008
7-preclinical
Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy.
PMID 17699769·Cancer Res·2007
7-preclinical
Hydroquinone: acute and subchronic toxicity studies with emphasis on neurobehavioral and nephrotoxic effects.
PMID 17030380·Food Chem Toxicol·2007
7-preclinical
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.
PMID 17473203·Clin Cancer Res·2007
3-trial
Translation elongation factor eEF1A2 is essential for post-weaning survival in mice.
PMID 17640869·J Biol Chem·2007
7-preclinical
The semi-permeability of silicone: a saline-filled breast implant with intraluminal and pericapsular Aspergillus flavus.
PMID 16996440·J Plast Reconstr Aesthet Surg·2006
5-case
Hydroquinone and its analogues in dermatology - a risk-benefit viewpoint.
PMID 17177740·J Cosmet Dermatol·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2608 FISHER CT N
WILSON, NC 27896 - Phone
- (252) 399-6377
Quick Facts
- NPI
- 1801161351
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile